Hong Kong
· Delayed Price · Currency is HKD Joinn Laboratories(China)Co.,Ltd. Statistics
Total Valuation
Joinn Laboratories(China)Co.,Ltd. has a market cap or net worth of HKD 14.42 billion. The enterprise value is 10.98 billion.
| Market Cap | 14.42B |
| Enterprise Value | 10.98B |
Important Dates
The next estimated earnings date is Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | Jun 28, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.19% |
| Shares Change (QoQ) | +20.52% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 444.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.09, with an EV/FCF ratio of 73.07.
| EV / Earnings | -10,859.51 |
| EV / Sales | 4.81 |
| EV / EBITDA | 30.09 |
| EV / EBIT | 47.86 |
| EV / FCF | 73.07 |
Financial Position
The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.11 |
| Quick Ratio | 2.74 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | 0.24 |
| Interest Coverage | 83.85 |
Financial Efficiency
Return on equity (ROE) is -0.11% and return on invested capital (ROIC) is 1.63%.
| Return on Equity (ROE) | -0.11% |
| Return on Assets (ROA) | 1.35% |
| Return on Capital (ROIC) | 1.63% |
| Revenue Per Employee | 937,539 |
| Profits Per Employee | -403 |
| Employee Count | 2,510 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 0.78 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.40% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -29.40% |
| 50-Day Moving Average | 8.69 |
| 200-Day Moving Average | 8.72 |
| Relative Strength Index (RSI) | 60.04 |
| Average Volume (20 Days) | 3,287,234 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Joinn Laboratories(China)Co.,Ltd. had revenue of HKD 2.35 billion and -1.01 million in losses. Loss per share was -0.00.
| Revenue | 2.35B |
| Gross Profit | 724.20M |
| Operating Income | 236.29M |
| Pretax Income | 49.92M |
| Net Income | -1.01M |
| EBITDA | 346.84M |
| EBIT | 236.29M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 3.57 billion in cash and 36.30 million in debt, giving a net cash position of 3.53 billion.
| Cash & Cash Equivalents | 3.57B |
| Total Debt | 36.30M |
| Net Cash | 3.53B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 8.85B |
| Book Value Per Share | 10.22 |
| Working Capital | 4.47B |
Cash Flow
In the last 12 months, operating cash flow was 406.23 million and capital expenditures -255.96 million, giving a free cash flow of 150.27 million.
| Operating Cash Flow | 406.23M |
| Capital Expenditures | -255.96M |
| Free Cash Flow | 150.27M |
| FCF Per Share | n/a |
Margins
Gross margin is 30.77%, with operating and profit margins of 10.04% and -0.04%.
| Gross Margin | 30.77% |
| Operating Margin | 10.04% |
| Pretax Margin | 2.12% |
| Profit Margin | -0.04% |
| EBITDA Margin | 14.74% |
| EBIT Margin | 10.04% |
| FCF Margin | 6.39% |
Dividends & Yields
Joinn Laboratories(China)Co.,Ltd. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | -59.09% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | -4.19% |
| Shareholder Yield | -4.19% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 20, 2023. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 20, 2023 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Joinn Laboratories(China)Co.,Ltd. has an Altman Z-Score of 6.13.
| Altman Z-Score | 6.13 |
| Piotroski F-Score | n/a |